{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:53:07Z","timestamp":1790218387070,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST40\/491-1"],"award-info":[{"award-number":["INST40\/491-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["CRC841, CRC877"],"award-info":[{"award-number":["CRC841, CRC877"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00210-018-1483-7","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T08:21:08Z","timestamp":1519892468000},"page":"523-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma"],"prefix":"10.1007","volume":"391","author":[{"given":"Kathrin","family":"Kaiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Prystaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Haffner-Luntzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bergdolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg H.","family":"Waetzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rose-John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-1979","authenticated-orcid":false,"given":"Anita","family":"Ignatius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"1483_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/154405910808700215","volume":"87","author":"ZS Ai-Aql","year":"2008","unstructured":"Ai-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA (2008) Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87:107\u2013118","journal-title":"J Dent Res"},{"key":"1483_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9894716","volume":"2016","author":"B Alper","year":"2016","unstructured":"Alper B, Erdogan B, Erdogan MO, Bozan K, Can M (2016) Associations of trauma severity with mean platelet volume and levels of systemic inflammatory markers (IL1beta, IL6, TNFalpha, and CRP). Mediat Inflamm 2016:9894716:1\u20134. \n                    https:\/\/doi.org\/10.1155\/2016\/9894716","journal-title":"Mediat Inflamm"},{"key":"1483_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/CCM.0b013e318211ff56","volume":"39","author":"T Barkhausen","year":"2011","unstructured":"Barkhausen T, Tschernig T, Rosenstiel P, van Griensven M, Vonberg RP, Dorsch M, Mueller-Heine A, Chalaris A, Scheller J, Rose-John S, Seegert D, Krettek C, Waetzig GH (2011) Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model. Crit Care Med 39:1407\u20131413. \n                    https:\/\/doi.org\/10.1097\/CCM.0b013e318211ff56","journal-title":"Crit Care Med"},{"key":"1483_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1189\/jlb.0810446","volume":"89","author":"O Bastian","year":"2011","unstructured":"Bastian O, Pillay J, Alblas J, Leenen L, Koenderman L, Blokhuis T (2011) Systemic inflammation and fracture healing. J Leukoc Biol 89:669\u2013673. \n                    https:\/\/doi.org\/10.1189\/jlb.0810446","journal-title":"J Leukoc Biol"},{"key":"1483_CR5","doi-asserted-by":"crossref","unstructured":"Beeton CA, Chatfield D, Brooks RA, Rushton N (2004) Circulating levels of interleukin-6 and its soluble receptor in patients with head injury and fracture Journal of Bone & Joint Surgery, British Volume 86-B:912","DOI":"10.1302\/0301-620X.86B6.14176"},{"key":"1483_CR6","doi-asserted-by":"publisher","first-page":"e0179512","DOI":"10.1371\/journal.pone.0179512","volume":"12","author":"S Bergdolt","year":"2017","unstructured":"Bergdolt S, Kovtun A, H\u00e4gele Y, Liedert A, Schinke T, Amling M, Huber-Lang M, Ignatius A (2017) Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. PLoS One 12:e0179512. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0179512","journal-title":"PLoS One"},{"key":"1483_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00005131-200305000-00006","volume":"17","author":"M Bhandari","year":"2003","unstructured":"Bhandari M, Tornetta P 3rd, Sprague S, Najibi S, Petrisor B, Griffith L, Guyatt GH (2003) Predictors of reoperation following operative management of fractures of the tibial shaft. J Orthop Trauma 17:353\u2013361","journal-title":"J Orthop Trauma"},{"key":"1483_CR8","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468\u20131486. \n                    https:\/\/doi.org\/10.1002\/jbmr.141","journal-title":"J Bone Miner Res"},{"key":"1483_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.15252\/emmm.201404487","volume":"7","author":"JK Chan","year":"2015","unstructured":"Chan JK, Glass GE, Ersek A, Freidin A, Williams GA, Gowers K, Espirito Santo AI, Jeffery R, Otto WR, Poulsom R, Feldmann M, Rankin SM, Horwood NJ, Nanchahal J (2015) Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response. EMBO Mol Med 7:547\u2013561. \n                    https:\/\/doi.org\/10.15252\/emmm.201404487","journal-title":"EMBO Mol Med"},{"key":"1483_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2012.1","volume":"8","author":"L Claes","year":"2012","unstructured":"Claes L, Recknagel S, Ignatius A (2012) Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 8:133\u2013143. \n                    https:\/\/doi.org\/10.1038\/nrrheum.2012.1","journal-title":"Nat Rev Rheumatol"},{"key":"1483_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/SHK.0b013e3181d8e687","volume":"34","author":"J Cuschieri","year":"2010","unstructured":"Cuschieri J, Bulger E, Schaeffer V, Sakr S, Nathens AB, Hennessy L, Minei J, Moore EE, O'Keefe G, Sperry J, Remick D, Tompkins R, Maier RV, Inflammation and the Host Response to Injury Collaborative Research Program (2010) Early elevation in random plasma IL-6 after severe injury is associated with development of organ failure. Shock 34:346\u2013351. \n                    https:\/\/doi.org\/10.1097\/SHK.0b013e3181d8e687","journal-title":"Shock"},{"key":"1483_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00198-010-1192-7","volume":"21","author":"CJ Edwards","year":"2010","unstructured":"Edwards CJ, Williams E (2010) The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis. Osteoporos Int 21:1287\u20131293. \n                    https:\/\/doi.org\/10.1007\/s00198-010-1192-7","journal-title":"Osteoporos Int"},{"key":"1483_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3899\/jrheum.150457","volume":"44","author":"F Espinoza","year":"2017","unstructured":"Espinoza F, Le Blay P, Combe B (2017) Biologic disease-modifying antirheumatic drug (bDMARD)-induced neutropenia: a registry from a retrospective cohort of patients with rheumatic diseases treated with 3 classes of intravenous bDMARD. J Rheumatol 44:844\u2013849","journal-title":"J Rheumatol"},{"key":"1483_CR14","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.4049\/jimmunol.181.3.2189","volume":"181","author":"CA Fielding","year":"2008","unstructured":"Fielding CA, McLoughlin RM, McLeod L, Colmont CS, Najdovska M, Grail D, Ernst M, Jones SA, Topley N, Jenkins BJ (2008) IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol 181:2189\u20132195. \n                    https:\/\/doi.org\/10.4049\/jimmunol.181.3.2189","journal-title":"J Immunol"},{"key":"1483_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/1753425908100016","volume":"14","author":"SB Flohe","year":"2008","unstructured":"Flohe SB, Flohe S, Schade FU (2008) Invited review: deterioration of the immune system after trauma: signals and cellular mechanisms. Innate Immun 14:333\u2013344. \n                    https:\/\/doi.org\/10.1177\/1753425908100016","journal-title":"Innate Immun"},{"key":"1483_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1757-7241-17-49","volume":"17","author":"M Frink","year":"2009","unstructured":"Frink M, van Griensven M, Kobbe P, Brin T, Zeckey C, Vaske B, Krettek C, Hildebrand F (2009) IL-6 predicts organ dysfunction and mortality in patients with multiple injuries. Scand J Trauma Resusc Emerg Med 17:49. \n                    https:\/\/doi.org\/10.1186\/1757-7241-17-49","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"1483_CR17","doi-asserted-by":"publisher","first-page":"42959","DOI":"10.1074\/jbc.M111.295758","volume":"286","author":"C Garbers","year":"2011","unstructured":"Garbers C, Thaiss W, Jones GW, Waetzig GH, Lorenzen I, Guilhot F, Lissilaa R, Ferlin WG, Gr\u00f6tzinger J, Jones SA, Rose-John S, Scheller J (2011) Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. J Biol Chem 286:42959\u201342970. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.295758","journal-title":"J Biol Chem"},{"key":"1483_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archsurg.135.3.291","volume":"135","author":"F Gebhard","year":"2000","unstructured":"Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Bruckner UB (2000) Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg 135:291\u2013295","journal-title":"Arch Surg"},{"key":"1483_CR19","doi-asserted-by":"publisher","first-page":"e116282","DOI":"10.1371\/journal.pone.0116282","volume":"9","author":"M Haffner-Luntzer","year":"2014","unstructured":"Haffner-Luntzer M, Heilmann A, Rapp AE, Beie S, Schinke T, Amling M, Ignatius A, Liedert A (2014) Midkine-deficiency delays chondrogenesis during the early phase of fracture healing in mice. PLoS One 9:e116282. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0116282","journal-title":"PLoS One"},{"key":"1483_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1677\/JOE-08-0568","volume":"201","author":"R Hardy","year":"2009","unstructured":"Hardy R, Cooper MS (2009) Bone loss in inflammatory disorders. J Endocrinol 201:309\u2013320. \n                    https:\/\/doi.org\/10.1677\/JOE-08-0568","journal-title":"J Endocrinol"},{"key":"1483_CR21","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.injury.2014.06.021","volume":"45","author":"J Hazeldine","year":"2014","unstructured":"Hazeldine J, Hampson P, Lord JM (2014) The impact of trauma on neutrophil function. Injury 45:1824\u20131833. \n                    https:\/\/doi.org\/10.1016\/j.injury.2014.06.021","journal-title":"Injury"},{"key":"1483_CR22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s12026-016-8868-9","volume":"64","author":"P Hoff","year":"2016","unstructured":"Hoff P, Gaber T, Strehl C, Schmidt-Bleek K, Lang A, Huscher D, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F (2016) Immunological characterization of the early human fracture hematoma. Immunol Res 64:1195\u20131206. \n                    https:\/\/doi.org\/10.1007\/s12026-016-8868-9","journal-title":"Immunol Res"},{"key":"1483_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","volume":"268","author":"T Jostock","year":"2001","unstructured":"Jostock T, M\u00fcllberg J, \u00d6zbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF, Rose-John S (2001) Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268:160\u2013167","journal-title":"Eur J Biochem"},{"key":"1483_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s004020000252","volume":"121","author":"AH Karladani","year":"2001","unstructured":"Karladani AH, Granhed H, Karrholm J, Styf J (2001) The influence of fracture etiology and type on fracture healing: a review of 104 consecutive tibial shaft fractures. Arch Orthop Trauma Surg 121:325\u2013328","journal-title":"Arch Orthop Trauma Surg"},{"key":"1483_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131194","volume":"10","author":"J Kemmler","year":"2015","unstructured":"Kemmler J, Bindl R, McCook O, Wagner F, Gr\u00f6ger M, Wagner K, Scheuerle A, Radermacher P, Ignatius A (2015) Exposure to 100% oxygen abolishes the impairment of fracture healing after thoracic trauma. PLoS One 10:e0131194. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0131194","journal-title":"PLoS One"},{"key":"1483_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/jor.22857","volume":"33","author":"C Kleber","year":"2015","unstructured":"Kleber C, Becker CA, Malysch T, Reinhold JM, Tsitsilonis S, Duda GN, Schmidt-Bleek K, Schaser KD (2015) Temporal profile of inflammatory response to fracture and hemorrhagic shock: proposal of a novel long-term survival murine multiple trauma model. J Orthop Res 33:965\u2013970. \n                    https:\/\/doi.org\/10.1002\/jor.22857","journal-title":"J Orthop Res"},{"key":"1483_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/01.shk.0000070739.34700.f6","volume":"19","author":"MW Knoferl","year":"2003","unstructured":"Knoferl MW, Liener UC, Seitz DH, Perl M, Bruckner UB, Kinzl L, Gebhard F (2003) Cardiopulmonary, histological, and inflammatory alterations after lung contusion in a novel mouse model of blunt chest trauma. Shock 19:519\u2013525. \n                    https:\/\/doi.org\/10.1097\/01.shk.0000070739.34700.f6","journal-title":"Shock"},{"key":"1483_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1359\/jbmr.2001.16.6.1004","volume":"16","author":"T Kon","year":"2001","unstructured":"Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004\u20131014. \n                    https:\/\/doi.org\/10.1359\/jbmr.2001.16.6.1004","journal-title":"J Bone Miner Res"},{"key":"1483_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.22203\/eCM.v032a10","volume":"32","author":"A Kovtun","year":"2016","unstructured":"Kovtun A, Bergdolt S, Wiegner R, Radermacher P, Huber-Lang M, Ignatius A (2016) The crucial role of neutrophil granulocytes in bone fracture healing. European Cells and Materials 32:152\u2013162. \n                    https:\/\/doi.org\/10.22203\/eCM.v032a10","journal-title":"European Cells and Materials"},{"key":"1483_CR30","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.injury.2007.10.003","volume":"38","author":"A Lenz","year":"2007","unstructured":"Lenz A, Franklin GA, Cheadle WG (2007) Systemic inflammation after trauma. Injury 38:1336\u20131345. \n                    https:\/\/doi.org\/10.1016\/j.injury.2007.10.003","journal-title":"Injury"},{"key":"1483_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bone.2016.02.020","volume":"86","author":"F Loi","year":"2016","unstructured":"Loi F, Cordova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB (2016) Inflammation, fracture and bone repair. Bone 86:119\u2013130. \n                    https:\/\/doi.org\/10.1016\/j.bone.2016.02.020","journal-title":"Bone"},{"key":"1483_CR32","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.bbamcr.2017.06.008","volume":"1864","author":"J Lokau","year":"2017","unstructured":"Lokau J, Agthe M, Flynn CM, Garbers C (2017) Proteolytic control of Interleukin-11 and Interleukin-6 biology. Biochim Biophys Acta 1864:2105\u20132117. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2017.06.008","journal-title":"Biochim Biophys Acta"},{"key":"1483_CR33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S0140-6736(14)60687-5","volume":"384","author":"JM Lord","year":"2014","unstructured":"Lord JM, Midwinter MJ, Chen YF, Belli A, Brohi K, Kovacs EJ, Koenderman L, Kubes P, Lilford RJ (2014) The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet 384:1455\u20131465. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(14)60687-5","journal-title":"Lancet"},{"key":"1483_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ni.2865","volume":"15","author":"J Mauer","year":"2014","unstructured":"Mauer J, Chaurasia B, Goldau J, Vogt MC, Ruud J, Nguyen KD, Theurich S, Hausen AC, Schmitz J, Br\u00f6nneke HS, Estevez E, Allen TL, Mesaros A, Partridge L, Febbraio MA, Chawla A, Wunderlich FT, Br\u00fcning JC (2014) Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol 15:423\u2013430. \n                    https:\/\/doi.org\/10.1038\/ni.2865","journal-title":"Nat Immunol"},{"key":"1483_CR35","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.4049\/jimmunol.0901929","volume":"184","author":"MM McFarland-Mancini","year":"2010","unstructured":"McFarland-Mancini MM et al (2010) Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J Immunol 184:7219\u20137228. \n                    https:\/\/doi.org\/10.4049\/jimmunol.0901929","journal-title":"J Immunol"},{"key":"1483_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bone.2008.10.039","volume":"44","author":"EF Morgan","year":"2009","unstructured":"Morgan EF, Mason ZD, Chien KB, Pfeiffer AJ, Barnes GL, Einhorn TA, Gerstenfeld LC (2009) Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. Bone 44:335\u2013344. \n                    https:\/\/doi.org\/10.1016\/j.bone.2008.10.039","journal-title":"Bone"},{"key":"1483_CR37","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","volume":"112","author":"N Nishimoto","year":"2008","unstructured":"Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T (2008) Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood 112:3959\u20133964. \n                    https:\/\/doi.org\/10.1182\/blood-2008-05-155846","journal-title":"Blood"},{"key":"1483_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11914-015-0260-5","volume":"13","author":"L Oei","year":"2015","unstructured":"Oei L, Rivadeneira F, Zillikens MC, Oei EH (2015) Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep 13:106\u2013115. \n                    https:\/\/doi.org\/10.1007\/s11914-015-0260-5","journal-title":"Curr Osteoporos Rep"},{"key":"1483_CR39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/BOT.0b013e3181ed1361","volume":"24","author":"HC Pape","year":"2010","unstructured":"Pape HC, Marcucio R, Humphrey C, Colnot C, Knobe M, Harvey EJ (2010) Trauma-induced inflammation and fracture healing. J Orthop Trauma 24:522\u2013525. \n                    https:\/\/doi.org\/10.1097\/BOT.0b013e3181ed1361","journal-title":"J Orthop Trauma"},{"key":"1483_CR40","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/01.CCM.0000207343.53990.A8","volume":"34","author":"M Perl","year":"2006","unstructured":"Perl M, Gebhard F, Braumuller S, Tauchmann B, Bruckner UB, Kinzl L, Knoferl MW (2006) The pulmonary and hepatic immune microenvironment and its contribution to the early systemic inflammation following blunt chest trauma. Crit Care Med 34:1152\u20131159. \n                    https:\/\/doi.org\/10.1097\/01.CCM.0000207343.53990.A8","journal-title":"Crit Care Med"},{"key":"1483_CR41","doi-asserted-by":"publisher","unstructured":"Prystaz K et al (2017) Distinct effects of IL-6 classic and trans-signaling in bone fracture healing. Am J Pathol. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2017.10.011","DOI":"10.1016\/j.ajpath.2017.10.011"},{"key":"1483_CR42","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2007-07-102137","volume":"111","author":"B Rabe","year":"2008","unstructured":"Rabe B, Chalaris A, May U, Waetzig GH, Seegert D, Williams AS, Jones SA, Rose-John S, Scheller J (2008) Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 111:1021\u20131028. \n                    https:\/\/doi.org\/10.1182\/blood-2007-07-102137","journal-title":"Blood"},{"key":"1483_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","volume":"339","author":"C Ramakers","year":"2003","unstructured":"Ramakers C, Ruijter JM, Deprez RHL, Moorman AFM (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339:62\u201366. \n                    https:\/\/doi.org\/10.1016\/s0304-3940(02)01423-4","journal-title":"Neurosci Lett"},{"key":"1483_CR44","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/jor.21148","volume":"28","author":"V R\u00f6ntgen","year":"2010","unstructured":"R\u00f6ntgen V, Blakytny R, Matthys R, Landauer M, Wehner T, G\u00f6ckelmann M, Jermendy P, Amling M, Schinke T, Claes L, Ignatius A (2010) Fracture healing in mice under controlled rigid and flexible conditions using an adjustable external fixator. J Orthop Res 28:1456\u20131462. \n                    https:\/\/doi.org\/10.1002\/jor.21148","journal-title":"J Orthop Res"},{"key":"1483_CR45","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"S Rose-John","year":"2012","unstructured":"Rose-John S (2012) IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci 8:1237\u20131247. \n                    https:\/\/doi.org\/10.7150\/ijbs.4989","journal-title":"Int J Biol Sci"},{"key":"1483_CR46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1517\/14728222.11.5.613","volume":"11","author":"S Rose-John","year":"2007","unstructured":"Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D (2007) The IL-6\/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11:613\u2013624. \n                    https:\/\/doi.org\/10.1517\/14728222.11.5.613","journal-title":"Expert Opin Ther Targets"},{"key":"1483_CR47","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878\u2013888. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034","journal-title":"Biochim Biophys Acta"},{"key":"1483_CR48","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.smim.2013.11.002","volume":"26","author":"J Scheller","year":"2014","unstructured":"Scheller J, Garbers C, Rose-John S (2014) Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities. Semin Immunol 26:2\u201312. \n                    https:\/\/doi.org\/10.1016\/j.smim.2013.11.002","journal-title":"Semin Immunol"},{"key":"1483_CR49","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","volume":"64","author":"D Schmidt-Arras","year":"2016","unstructured":"Schmidt-Arras D, Rose-John S (2016) IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol 64:1403\u20131415. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2016.02.004","journal-title":"J Hepatol"},{"key":"1483_CR50","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/imt-2016-0020","volume":"8","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2016) Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 8:959\u2013970","journal-title":"Immunotherapy"},{"key":"1483_CR51","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00113-013-2543-6","volume":"117","author":"M Griensven van","year":"2014","unstructured":"van Griensven M (2014) Cytokines as biomarkers in polytraumatized patients. Unfallchirurg 117:699\u2013702. \n                    https:\/\/doi.org\/10.1007\/s00113-013-2543-6","journal-title":"Unfallchirurg"},{"key":"1483_CR52","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00264-013-2261-2","volume":"38","author":"G Volpin","year":"2014","unstructured":"Volpin G, Cohen M, Assaf M, Meir T, Katz R, Pollack S (2014) Cytokine levels (IL-4, IL-6, IL-8 and TGFbeta) as potential biomarkers of systemic inflammatory response in trauma patients. Int Orthop 38:1303\u20131309. \n                    https:\/\/doi.org\/10.1007\/s00264-013-2261-2","journal-title":"Int Orthop"},{"key":"1483_CR53","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/jor.21367","volume":"29","author":"A Wallace","year":"2011","unstructured":"Wallace A, Cooney TE, Englund R, Lubahn JD (2011) Effects of interleukin-6 ablation on fracture healing in mice. J Orthop Res 29:1437\u20131442. \n                    https:\/\/doi.org\/10.1002\/jor.21367","journal-title":"J Orthop Res"},{"key":"1483_CR54","doi-asserted-by":"publisher","unstructured":"Walters G, Pountos I, Giannoudis PV (2017) The cytokines and microenvironment of fracture haematoma: current evidence J Tissue Eng Regen Med:1\u201316j \n                    https:\/\/doi.org\/10.1002\/term.2593","DOI":"10.1002\/term.2593"},{"key":"1483_CR55","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/rheumatology\/keu035","volume":"53","author":"HL Wright","year":"2014","unstructured":"Wright HL, Cross AL, Edwards SW, Moots RJ (2014) Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo. Rheumatology (Oxford) 53:1321\u20131331. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/keu035","journal-title":"Rheumatology (Oxford)"},{"key":"1483_CR56","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1189\/jlb.3A0515-207R","volume":"99","author":"I Yan","year":"2016","unstructured":"Yan I, Schwarz J, L\u00fccke K, Schumacher N, Schumacher V, Schmidt S, Rabe B, Saftig P, Donners M, Rose-John S, Mittr\u00fccker HW, Chalaris A (2016) ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Ralpha from the cell surface of leukocytes during inflammatory responses. J Leukoc Biol 99:749\u2013760. \n                    https:\/\/doi.org\/10.1189\/jlb.3A0515-207R","journal-title":"J Leukoc Biol"},{"key":"1483_CR57","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.bone.2007.07.022","volume":"41","author":"X Yang","year":"2007","unstructured":"Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko Camacho N, Bostrom MP (2007) Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41:928\u2013936. \n                    https:\/\/doi.org\/10.1016\/j.bone.2007.07.022","journal-title":"Bone"},{"key":"1483_CR58","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1172\/JCI64931","volume":"123","author":"H Zhang","year":"2013","unstructured":"Zhang H, Neuh\u00f6fer P, Song L, Rabe B, Lesina M, Kurkowski MU, Treiber M, Wartmann T, Regn\u00e9r S, Thorlacius H, Saur D, Weirich G, Yoshimura A, Halangk W, Mizgerd JP, Schmid RM, Rose-John S, Alg\u00fcl H (2013) IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. J Clin Invest 123:1019\u20131031. \n                    https:\/\/doi.org\/10.1172\/JCI64931","journal-title":"J Clin Invest"},{"key":"1483_CR59","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.2775","volume":"151","author":"R Zura","year":"2016","unstructured":"Zura R, Xiong Z, Einhorn T, Watson JT, Ostrum RF, Prayson MJ, Della Rocca GJ, Mehta S, McKinley T, Wang Z, Steen RG (2016) Epidemiology of fracture nonunion in 18 human bones. JAMA Surg 151:e162775. \n                    https:\/\/doi.org\/10.1001\/jamasurg.2016.2775","journal-title":"JAMA Surg"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-018-1483-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T21:57:31Z","timestamp":1551391051000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-018-1483-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1007\/s00210-018-1483-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Prof. Dr. Stefan Rose-John is an inventor on patents describing the function of sgp130Fc. He is also a shareholder of the CONARIS Research Institute (Kiel, Germany), which is commercially developing sgp130Fc proteins as therapeutics for inflammatory diseases. Georg H. Waetzig is an inventor on patents describing the function of sgp130Fc and an employee of CONARIS Research Institute AG. All other authors have no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}